Atlas Trials

DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations

Clinical trial NCT06833814 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06833814
Sponsor
Andréanne Côté
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Asthma Exacerbations
Start date
2025-02-17
Primary completion
2025-12-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.